Factors Predicting the Presence of Maternal Cells in Cord Blood and Associated Changes in Immune Cell Composition.
HLA compatibility
NK cells
PAPP-A
cord blood
maternal microchimerism
transplantation
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
09
01
2021
accepted:
18
03
2021
entrez:
10
5
2021
pubmed:
11
5
2021
medline:
25
9
2021
Statut:
epublish
Résumé
Cord blood (CB) samples are increasingly used as a source of hematopoietic stem cells in transplantation settings. Maternal cells have been detected in CB samples and their presence is associated with a better graft outcome. However, we still do not know what influences the presence of maternal microchimerism (MMc) in CB samples and whether their presence influences CB hematopoietic cell composition. Here we test whether genetic, biological, anthropometric and/or obstetrical parameters influence the frequency and/or quantity of maternal Mc in CB samples from 55 healthy primigravid women. Mc was evaluated by targeting non-shared, non-inherited Human Leukocyte Antigen (HLA)-specific real-time quantitative PCR in whole blood and four cell subsets (T, B lymphocytes, granulocytes and/or hematopoietic progenitor cells). Furthermore CB samples were analyzed for their cell composition by flow cytometry and categorized according to their microchimeric status. MMc was present in 55% of CB samples in at least one cell subset or whole blood, with levels reaching up to 0.3% of hematopoietic progenitor cells. Two factors were predictive of the presence of MMc in CB samples: high concentrations of maternal serological Pregnancy-Associated-Protein-A at first trimester of pregnancy ( We have identified two factors, measurable at early pregnancy, predicting the presence of maternal cells in CB samples at delivery. We have shown that MMc in CB samples could have an influence on the hematopoietic composition of fetal cells. CD56 is the phenotypic marker of natural killer cells (NK) and NK cells are known to be the main effector for graft versus leukemia reactions early after hematopoietic stem cell transplantation. These results emphasize the importance of MMc investigation for CB banking strategies.
Sections du résumé
Background
Cord blood (CB) samples are increasingly used as a source of hematopoietic stem cells in transplantation settings. Maternal cells have been detected in CB samples and their presence is associated with a better graft outcome. However, we still do not know what influences the presence of maternal microchimerism (MMc) in CB samples and whether their presence influences CB hematopoietic cell composition.
Patients and Methods
Here we test whether genetic, biological, anthropometric and/or obstetrical parameters influence the frequency and/or quantity of maternal Mc in CB samples from 55 healthy primigravid women. Mc was evaluated by targeting non-shared, non-inherited Human Leukocyte Antigen (HLA)-specific real-time quantitative PCR in whole blood and four cell subsets (T, B lymphocytes, granulocytes and/or hematopoietic progenitor cells). Furthermore CB samples were analyzed for their cell composition by flow cytometry and categorized according to their microchimeric status.
Results
MMc was present in 55% of CB samples in at least one cell subset or whole blood, with levels reaching up to 0.3% of hematopoietic progenitor cells. Two factors were predictive of the presence of MMc in CB samples: high concentrations of maternal serological Pregnancy-Associated-Protein-A at first trimester of pregnancy (
Conclusions
We have identified two factors, measurable at early pregnancy, predicting the presence of maternal cells in CB samples at delivery. We have shown that MMc in CB samples could have an influence on the hematopoietic composition of fetal cells. CD56 is the phenotypic marker of natural killer cells (NK) and NK cells are known to be the main effector for graft versus leukemia reactions early after hematopoietic stem cell transplantation. These results emphasize the importance of MMc investigation for CB banking strategies.
Identifiants
pubmed: 33968049
doi: 10.3389/fimmu.2021.651399
pmc: PMC8100674
doi:
Substances chimiques
CD56 Antigen
0
NCAM1 protein, human
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
651399Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2021 Haddad, Karlmark, Donato, Martin, Bretelle, Lesavre, Cocallemen, Martin, Picard, Roudier, Desbriere and Lambert.
Déclaration de conflit d'intérêts
The authors declare that the research was construed in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.
Références
J Clin Invest. 1999 Jul;104(1):41-7
pubmed: 10393697
J Hematother. 1993 Summer;2(2):235-9
pubmed: 7921983
Lab Invest. 2006 Nov;86(11):1185-92
pubmed: 16969370
Blood. 2013 Jul 25;122(4):491-8
pubmed: 23673863
Transfus Apher Sci. 2012 Feb;46(1):7-13
pubmed: 22192902
N Engl J Med. 1989 Oct 26;321(17):1174-8
pubmed: 2571931
Biol Blood Marrow Transplant. 2013 May;19(5):682-91
pubmed: 23142329
Prenat Diagn. 2002 Sep;22(9):778-82
pubmed: 12224070
BMJ. 1996 Dec 7;313(7070):1445-9
pubmed: 8973233
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3149-53
pubmed: 10077652
Blood. 1994 Jan 15;83(2):340-4
pubmed: 8286734
Bone Marrow Transplant. 2021 May;56(5):1090-1098
pubmed: 33257776
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2190-1
pubmed: 22323582
J Pediatr Gastroenterol Nutr. 2009 Oct;49(4):488-92
pubmed: 19590453
Cell Transplant. 2019 May;28(5):522-528
pubmed: 29947261
Front Immunol. 2017 Mar 23;8:329
pubmed: 28386260
Pediatr Res. 2004 Jul;56(1):73-8
pubmed: 15128924
Med J Aust. 2006 Apr 17;184(8):407-10
pubmed: 16618241
Br J Haematol. 2016 Feb;172(3):360-70
pubmed: 26577457
J Clin Med. 2019 Nov 14;8(11):
pubmed: 31739455
Biol Blood Marrow Transplant. 2012 Dec;18(12):1890-6
pubmed: 22814031
Arthritis Rheum. 2004 Mar;50(3):906-14
pubmed: 15022334
Hum Reprod. 2009 Jun;24(6):1330-8
pubmed: 19246467
Clin Chem. 2000 Sep;46(9):1301-9
pubmed: 10973858
J Pediatr Surg. 2007 Dec;42(12):2097-101
pubmed: 18082716
Tohoku J Exp Med. 2008 May;215(1):23-32
pubmed: 18509232
J Pediatr Gastroenterol Nutr. 2020 Sep;71(3):321-327
pubmed: 32833392
Front Immunol. 2017 Jul 24;8:892
pubmed: 28791027
Oncoimmunology. 2017 Mar 31;6(5):e1311436
pubmed: 28638735
Arthritis Rheum. 2009 Jan;60(1):73-80
pubmed: 19117368
Lancet Haematol. 2019 Nov;6(11):e573-e584
pubmed: 31477550
Blood. 1995 Oct 1;86(7):2829-32
pubmed: 7545474
J Ultrasound Med. 2009 Dec;28(12):1615-22
pubmed: 19933473
Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):705-8
pubmed: 8570620
Prenat Diagn. 2003 May;23(5):385-8
pubmed: 12749035
N Engl J Med. 2014 Jul 24;371(4):339-48
pubmed: 25054717
Science. 2008 Dec 5;322(5907):1562-5
pubmed: 19056990
Am J Obstet Gynecol. 1964 Mar 1;88:565-71
pubmed: 14128187
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19952-7
pubmed: 19901324
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2509-14
pubmed: 22232664
Pediatr Diabetes. 2019 Sep;20(6):728-735
pubmed: 31173445
J Matern Fetal Neonatal Med. 2017 Nov;30(21):2613-2619
pubmed: 27923274
N Engl J Med. 2016 Dec;375(22):2204-2205
pubmed: 27959748
BJOG. 2000 Oct;107(10):1265-70
pubmed: 11028579
Sci Rep. 2019 Mar 27;9(1):5247
pubmed: 30918307
Bone Marrow Transplant. 1998 Jun;21(11):1097-9
pubmed: 9645571
Exp Hematol. 1995 Dec;23(14):1601-5
pubmed: 8542953